Rapivab
NDC Package 61364-181-03

11-digit billing NDC: 61364018103 · Billing unit: ML · 60 ML per package
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Rapivab is indicated for the treatment of acute uncomplicated influenza in patients 2 years and older who have been symptomatic for no more than 2 days. Marketed by Seqirus Usa Inc., this product is identified by NDC 61364-181 and is authorized under FDA application NDA206426.

Identification & Billing

NDC Package Code
61364-181-03
Package Description
3 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS (61364-181-01)
Product Code
61364-181
11-Digit Billing Format
61364018103
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
60 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Rapivab
Dosage Form
-
Usage Information
RAPIVAB is indicated for the treatment of acute uncomplicated influenza in patients 2 years and older who have been symptomatic for no more than 2 days.

Regulatory & Marketing

Labeler Name
Seqirus Usa Inc.
FDA Application #
NDA206426
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-20-2014
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61364-181-03 identifies a specific commercial package of 3 vial, glass in 1 carton / 20 ml in 1 vial, glass (61364-181-01) of Rapivab, labeled by Seqirus Usa Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 60 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Seqirus Usa Inc. on December 20, 2014. The current certification is valid through December 31, 2021.

How is this Seqirus Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61364018103. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61364-181-03
11-Digit CMS (5-4-2)
61364-0181-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.